22-23766131-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_213720.3(CHCHD10):c.406C>T(p.His136Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. H136H) has been classified as Uncertain significance.
Frequency
Consequence
NM_213720.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHCHD10 | NM_213720.3 | c.406C>T | p.His136Tyr | missense_variant | 3/4 | ENST00000484558.3 | |
CHCHD10 | NM_001301339.2 | c.427C>T | p.His143Tyr | missense_variant | 3/4 | ||
CHCHD10 | NR_125755.2 | n.451C>T | non_coding_transcript_exon_variant | 3/4 | |||
CHCHD10 | NR_125756.2 | n.284C>T | non_coding_transcript_exon_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHCHD10 | ENST00000484558.3 | c.406C>T | p.His136Tyr | missense_variant | 3/4 | 1 | NM_213720.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249924Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135386
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461388Hom.: 0 Cov.: 65 AF XY: 0.00000138 AC XY: 1AN XY: 726970
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152226Hom.: 0 Cov.: 30 AF XY: 0.0000134 AC XY: 1AN XY: 74440
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at